Rachel E. Jenkins

814 total citations
19 papers, 372 citations indexed

About

Rachel E. Jenkins is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, Rachel E. Jenkins has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 10 papers in Rheumatology and 7 papers in Genetics. Recurrent topics in Rachel E. Jenkins's work include Autoimmune Bullous Skin Diseases (10 papers), Urticaria and Related Conditions (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Rachel E. Jenkins is often cited by papers focused on Autoimmune Bullous Skin Diseases (10 papers), Urticaria and Related Conditions (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Rachel E. Jenkins collaborates with scholars based in United Kingdom, United States and Thailand. Rachel E. Jenkins's co-authors include Martin M. Black, Stefanie A Jones, Jeff K. Shornick, D. McGibbon, David Briggs, Céline Besse, Susan Kelly, S.E. HANDFIELD-JONES, Sean Whittaker and Christina M. Ambros‐Rudolph and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Lara D. Veeken.

In The Last Decade

Rachel E. Jenkins

19 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel E. Jenkins United Kingdom 11 252 231 154 55 51 19 372
Belinda Welsh Australia 10 176 0.7× 131 0.6× 120 0.8× 11 0.2× 76 1.5× 13 316
Anat Bialy‐Golan Israel 8 182 0.7× 125 0.5× 97 0.6× 54 1.0× 30 0.6× 12 247
Chuda Rujitharanawong Thailand 11 80 0.3× 159 0.7× 93 0.6× 18 0.3× 84 1.6× 43 287
Riccardo Pellicano Italy 10 109 0.4× 84 0.4× 48 0.3× 69 1.3× 104 2.0× 15 293
Burçe Can Türkiye 10 104 0.4× 98 0.4× 47 0.3× 11 0.2× 84 1.6× 26 270
C. Belajouza Tunisia 9 62 0.2× 45 0.2× 26 0.2× 34 0.6× 74 1.5× 52 242
Marilyn B. Ekins United States 7 119 0.5× 95 0.4× 85 0.6× 7 0.1× 20 0.4× 8 313
Laia Curto‐Barredo Spain 12 224 0.9× 423 1.8× 252 1.6× 28 0.5× 131 2.6× 40 508
W. Kastrup Sweden 12 138 0.5× 90 0.4× 38 0.2× 6 0.1× 58 1.1× 20 364
İnci Mevlitoğlu Türkiye 10 108 0.4× 163 0.7× 49 0.3× 4 0.1× 200 3.9× 24 416

Countries citing papers authored by Rachel E. Jenkins

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Jenkins more than expected).

Fields of papers citing papers by Rachel E. Jenkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Jenkins. The network helps show where Rachel E. Jenkins may publish in the future.

Co-authorship network of co-authors of Rachel E. Jenkins

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Jenkins. A scholar is included among the top collaborators of Rachel E. Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Jenkins. Rachel E. Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jenkins, Rachel E., et al.. (2023). BT09 Clinical performance of an artificial intelligence-based medical device deployed within an urgent suspected skin cancer pathway. British Journal of Dermatology. 188(Supplement_4). 3 indexed citations
2.
Chi, Ching‐Chi, Wang Sh, R. Charles‐Holmes, et al.. (2009). Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. British Journal of Dermatology. 160(6). 1222–1228. 72 indexed citations
3.
Wakelin, S. H., Rachel E. Jenkins, R. J. G. Rycroft, John Mcfadden, & Ian R. White. (1999). Patch testing with natural rubber latex. Contact Dermatitis. 40(2). 89–93. 18 indexed citations
4.
Choy, Ernest, Lorraine Gambling, Rachel E. Jenkins, et al.. (1997). Nickel contamination of gold salts: link with gold-induced skin rash. Lara D. Veeken. 36(10). 1054–1058. 3 indexed citations
5.
Jenkins, Rachel E., Stefanie A Jones, & Martin M. Black. (1996). Conversion of pemphigoid gestationis to bullous pemphigoid--two refractory cases highlighting this association.. PubMed. 135(4). 595–8. 28 indexed citations
6.
Amagai, Masayuki, Mari Higashiyama, Koji Hashimoto, et al.. (1996). Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen. Journal of Dermatological Science. 13(2). 112–117. 21 indexed citations
7.
Jenkins, Rachel E., Stefanie A Jones, & Martin M. Black. (1996). Conversion of pemphigoid gestationis to bullous pemphigoid— two refractory cases highlighting this association. British Journal of Dermatology. 135(4). 595–598. 26 indexed citations
8.
Jenkins, Rachel E., Stefanie A Jones, & Martin M. Black. (1996). Conversion of pemphigoid gestationis to bullous pemphigoid- two refractory cases highlighting this association. British Journal of Dermatology. 135(4). 595–598. 3 indexed citations
9.
Shornick, Jeff K., Rachel E. Jenkins, Carol M. Artlett, et al.. (1995). Class II MHC typing in pemphigoid gestationis. Clinical and Experimental Dermatology. 20(2). 123–126. 31 indexed citations
10.
11.
Jenkins, Rachel E., et al.. (1994). Neonatal lupus erythematosus. Clinical and Experimental Dermatology. 19(5). 409–411. 14 indexed citations
12.
Phillips, William G., et al.. (1994). Captopril-induced lichenoid eruption. Clinical and Experimental Dermatology. 19(4). 317–320. 8 indexed citations
13.
Jenkins, Rachel E.. (1994). Cutaneous Crystalline Deposits in Myeloma. Archives of Dermatology. 130(4). 484–484. 21 indexed citations
14.
HANDFIELD-JONES, S.E., Rachel E. Jenkins, Sean Whittaker, Céline Besse, & D. McGibbon. (1993). The anticonvulsant hypersensitivity syndrome. British Journal of Dermatology. 129(2). 175–177. 53 indexed citations
15.
Shornick, Jeff K., Rachel E. Jenkins, David Briggs, et al.. (1993). Anti-HLA antibodies in pemphigoid gestationis (herpes gestationis). British Journal of Dermatology. 129(3). 257–259. 21 indexed citations
16.
Shornick, Jeff K., Carol M. Artlett, Rachel E. Jenkins, et al.. (1993). Complement polymorphism in herpes gestationis: Association with C4 null allele. Journal of the American Academy of Dermatology. 29(4). 545–549. 33 indexed citations
17.
Jenkins, Rachel E., Jeff K. Shornick, & Martin M. Black. (1993). Pemphigoid gestationis. Journal of the European Academy of Dermatology and Venereology. 2(3). 163–173. 10 indexed citations
18.
Jenkins, Rachel E., et al.. (1992). Artefacts in immunofluorescence microscopy: a potential source of diagnostic confusion. Journal of the European Academy of Dermatology and Venereology. 1(3). 171–177. 2 indexed citations
19.
Irving, William L., et al.. (1985). Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A. Cellular Immunology. 96(2). 245–254. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Belinda Welsh Breakdown of academic impact, for papers by Anat Bialy‐Golan Breakdown of academic impact, for papers by Chuda Rujitharanawong Breakdown of academic impact, for papers by Riccardo Pellicano Breakdown of academic impact, for papers by Burçe Can Breakdown of academic impact, for papers by C. Belajouza Breakdown of academic impact, for papers by Marilyn B. Ekins Breakdown of academic impact, for papers by Laia Curto‐Barredo Breakdown of academic impact, for papers by W. Kastrup Breakdown of academic impact, for papers by İnci Mevlitoğlu
Rankless by CCL
2026